Estimating the harms of nicotine-containing products using the MCDA approach

European Addiction Research

Volumn 20, Issue 5, 2014, Pages 218-225

  Nutt, David J ^a   Phillips, Lawrence D ^b   Balfour, David ^f   Curran, H Valerie ^c   Dockrell, Martin ^d   Foulds, Jonathan ^h   Fagerstrom, Karl ⁱ   Letlape, Kgosi ^k   Milton, Anders ^j   Polosa, Riccardo ^l   Ramsey, John ^e   Sweanor, David ^g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Action on Smoking and Health   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

^g UNIVERSITY OF OTTAWA   (Canada)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

ⁱ Smoker's Information Centre   (Sweden)

^j World Medical Association Milton Consulting   (Sweden)

^k World Medical Association   (South Africa)

^l UNIVERSITY OF CATANIA   (Italy)

more..

Author keywords

Electronic cigarettes; ENDS (electronic nicotine delivery systems); Harm assessment; Multi criteria decision analysis; Oral tobacco products; Smoked tobacco products

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE; NICOTINE PATCH; NOSE SPRAY;

ARTICLE; ASSESSMENT OF HUMANS; CLINICAL CLASSIFICATION; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MORBIDITY; MORTALITY; MULTICRITERIA DECISION ANALYSIS; PRIORITY JOURNAL; SMALL CIGAR; SMOKELESS TOBACCO; SMOKING; SMOKING AND SMOKING RELATED PHENOMENA; TOBACCO; WATER PIPE; ADVERSE EFFECTS; RISK ASSESSMENT; SMOKING CESSATION;

HUMANS; NICOTINE; RISK ASSESSMENT; SMOKING CESSATION; TOBACCO PRODUCTS;

EID: 84897360903     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000360220     Document Type: Article

References (27)

1. Warner KE: The role of research in international tobacco control. Am J Public Health 2005; 95: 976-984.
2. Cahill K, Stevens S, Perera R, Lancaster T: Pharmacological interventions for smoking cessation: an overview and network metaanalysis. Cochrane Database Syst Rev 2013; 5:CD009329.
3. Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF: Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 2002; 77: 683-687.
4. Balfour DJ: The neuronal pathways mediating the behavioural and addictive properties of nicotine. Handb Exp Pharmacol 2009; 192: 209-233.
5. Fowler JS, Logan J, Wang GJ, Volkow ND: Monoamine oxidase and cigarette smoking. Neurotoxicology 2003; 24: 75-82.
6. Rose JE: Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006; 184: 274-285.
7. Fagerstrom K, Eissenberg T: Dependence to tobacco and nicotine products: a case for product specific assessment. Nicotine Tob Res 2012; 14: 1382-1390.
8. Brennan KA, Crowther A, Putt F, Roper V, Waterhouse U, Truman P: Tobacco particulate matter self-administration in rats: differential effects of tobacco type. Addict Biol 2013, Epub ahead of print.
9. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, Nides MA, Kiley JP: Safety of nicotine polacrilex gum used by 3, 094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996; 109: 438-445.
10. Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS: Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res 2009; 11: 99-105.
11. Tonini G, D'Onofrio L, Dell'Aquila E, Pezzuto A: New molecular insights in tobacco-induced lung cancer. Future Oncol 2013; 9: 649-655.
12. Slotkin TA, Lappi SE, Seidler FJ: Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? Brain Res Bull 1993; 31: 319-328.
13. Levin ED, Lawrence S, Petro A, Horton K, Seidler FJ, Slotkin TA: Increased nicotine selfadministration following prenatal exposure in female rats. Pharmacol Biochem Behav 2006; 85: 669-674.
14. England LJ, Kim SY, Tomar SL, Ray CS, Gupta PC, Eissenberg T, Cnattingius S, Bernert JT, Tita AT, Winn DM, Djordjevic MV, Lambe M, Stamilio D, Chipato T, Tolosa JE: Noncigarette tobacco use among women and adverse pregnancy outcomes. Acta Obstet Gynecol Scand 2010; 89: 454-464.
15. Bruin JE, Gerstein HC, Holloway AC: Longterm consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci 2010; 116: 364-374.
16. Stepanov I, Yershova K, Carmella S, Upadhyaya P, Hecht SS: Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products. Nicotine Tob Res 2013; 15: 1305-1310.
17. Leone A: Smoking and hypertension: independent or additive effects to determining vascular damage? Curr Vasc Pharmacol 2011; 9: 585-593.
18. Lee PN: Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011; 59: 197-214.
19. Ayo-Yusuf OA, Burns DM: The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries. Tob Control 2012; 21: 245-251.
20. Javed F, Chotai M, Mehmood A, Almas K: Oral mucosal disorders associated with habitual gutka usage: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 857-864.
21. Maziak W, Ward KD, Afifi Soweid RA, Eissenberg T: Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control 2004; 13: 327-333.
22. Cobb CO, Shihadeh A, Weaver MF, Eissenberg T: Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob Res 2011; 13: 78-87.
23. Saitta D, Ferro GA, Polosa R: Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis 2014;5:50-61.
24. Dodgson J, Spackman M, Pearman A, Phillips L: Multi-Criteria Analysis: A Manual (2000); ed 2. London, Department for Communities and Local Government, 2009.
25. Nutt DJ, King LA, Phillips LD, Independent Scientific Committee on Drugs: Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376: 1558-1565.
26. Advisory Council on the Misuse of Drugs: Consideration of the Use of Multi-Criteria Decision Analysis in Drug Harm Decision Making. London, Home Office, 2010.
27. Farsalinos KE, Polosa R: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Safety 2014;2:67-86.